The Ensign Group, Inc.

A$243.12A$-0.23 (-0.10%)
Last updated on --.

The Ensign Group, Inc. price

24 Hours-0.10%-A$0.23153
30 days-0.80%-A$1.956
60 days-8.02%-A$21.23
90 days+0.35%+A$0.84848

About The Ensign Group, Inc.

The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.

Stock ticker
ENSG
Company
The Ensign Group, Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
10001069
Launch date
Nov 9, 2007
Listed exchange
NASDAQ

Financials

Q2 FY2026 Earnings
Report period: Apr 1, 2026 – Jun 30, 2026

Summary: ENSG reported Revenue of 1.44B (+17.33%), meeting expectations; EPS of 1.92 (+20.75%), beating expectations.

Revenue (USD)Met1.44B+17.32%1.44B+18.17%-1.09M-0.08%
EPS (USD)Beat1.92+20.75%1.80+16.12%0.12+6.66%
Financial estimates
● Actual● Estimate
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
1.441.421.611.671.68
+18.03%+5.97%+18.38%+21.89%+16.66%
● EPS● YoY
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
4.93B5.23B5.46B5.61B5.75B
2.91B3.10B3.23B3.24B3.30B
59.00%59.38%59.09%57.77%57.46%
● Assets● Liabilities● Ratio
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
155.73M153.00M183.32M100.15M171.95M
+102.41%+13.77%+82.48%+38.67%+10.41%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.10.08%
BAILLIE GIFFORD & CO8.67%
VANGUARD PORTFOLIO MANAGEMENT LLC4.94%
VANGUARD CAPITAL MANAGEMENT LLC4.52%
FMR LLC4.38%
Others67.37%
Institutions
% Owned92.43%+0.53%
Shares held53.40M+308.27K
Institutions560-22
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.10.08%-1.52M
BAILLIE GIFFORD & CO8.67%+203.10K
VANGUARD PORTFOLIO MANAGEMENT LLC4.94%-253.74K
VANGUARD CAPITAL MANAGEMENT LLC4.52%+31.71K
FMR LLC4.38%+243.89K

Dividends

Dividends
Last ex-dividend: Sep 30, 2026 Cash dividend: 0.07 USD per share
Dividend yield TTM
0.15%
Payout ratio LFY
4.32%
Frequency
Quarterly
20222023202420252026
0.220.230.240.250.20
+0.23%+0.20%+0.18%+0.14%+0.15%
Dividend amount (USD)Dividend yield
Stock splits
Launch date: Nov 9, 2007
DateRatio
Oct 1, 20191000 → 1069
Dec 24, 20151 → 2
Jun 3, 20141000 → 1833

The Ensign Group, Inc. conversion tables

ENSGENSG
AUDAUD
0.5 ENSG121.56 AUD
1 ENSG243.12 AUD
5 ENSG1,215.61 AUD
10 ENSG2,431.23 AUD
AUDAUD
ENSGENSG
0.5 AUD0.0020566 ENSG
1 AUD0.0041131 ENSG
5 AUD0.020566 ENSG
10 AUD0.041131 ENSG

More to explore

FAQ

ENSG is trading at A$243.12, -0.10% over the last 24 hours. Track live moves on the price chart at the top of this page.

The ENSG stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ENSG is currently trading at A$243.12, -0.10% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ENSG price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ENSG's P/E ratio is currently 26.49 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ENSG; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ENSG's historical range and other companies in the Healthcare sector.

The Ensign Group, Inc.'s market cap is currently 14.16B AUD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.